Patents by Inventor Darius KAVALIAUSKAS

Darius KAVALIAUSKAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLYCEROL-FREE FORMULATIONS FOR REVERSE TRANSCRIPTASES
    Publication number: 20220372460
    Abstract: Glycerol-free enzyme formulations are described. In some embodiments, a glycerol-free enzyme formulation is stabilized by high salt concentration. The glycerol free enzyme formulation may comprise a reverse transcriptase enzyme.
    Type: Application
    Filed: February 23, 2022
    Publication date: November 24, 2022
    Inventors: Juozas SIURKUS, Darius KAVALIAUSKAS, Daumantas MATULIS, Lina BARANAUSKIENE
  • Glycerol-free formulations for reverse transcriptases
    Patent number: 11268084
    Abstract: Glycerol-free enzyme formulations are described. In some embodiments, a glycerol-free enzyme formulation is stabilized by high salt concentration. The glycerol free enzyme formulation may comprise a reverse transcriptase enzyme.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: March 8, 2022
    Assignee: Thermo Fisher Scientific Baltics, UAB
    Inventors: Juozas Siurkus, Darius Kavaliauskas, Daumantas Matulis, Lina Baranauskiene
  • GLYCEROL-FREE FORMULATIONS FOR REVERSE TRANSCRIPTASES
    Publication number: 20200248167
    Abstract: Glycerol-free enzyme formulations are described. In some embodiments, a glycerol-free enzyme formulation is stabilized by high salt concentration. The glycerol free enzyme formulation may comprise a reverse transcriptase enzyme.
    Type: Application
    Filed: August 2, 2018
    Publication date: August 6, 2020
    Inventors: Juozas SIURKUS, Darius KAVALIAUSKAS, Daumantas MATULIS, Lina BARANAUSKIENE